Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
-
April
-
May
-
June
-
July
- August -
September
-
Oktober
-
November
-
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
-
2016
-
2017
-
2018
- 2019 -
2020
-
2021
-
2022
-
2023
-
2024
-
2025
August 2019 - 29 products
IP
CI
Efavirenz/Emtricitabin/Tenofovir
Viatris
30
526.02
588.50
10 %
Mylan: 3 Active Agents
Viatris Pharma GmbH
●
A / SL / SG
FB
G
L
IP
CI
Pelgraz 6 mg/ 0.6 ml
1001.72
1105.85
10 %
Injection solution in prefilled syringe: Pegfilgrastimum 6mg / 0.6ml
Accord Healthcare AG
A / SL
FB
G
IP
CI
Fampyra 10 mg
4 x 14
PR
PR
k.A.
Delayed release tablets: Fampridinum 10 mg
Merz Pharma (Schweiz) AG
B
FB
G
IP
Docetaxel Accord 20 mg/1 ml
47.41
68.00
10 %
Concentrate for infusion: Docetaxelum 20 mg/ml
Accord Healthcare AG
A / SL / SG
FB
G
IP
Docetaxel Accord 80 mg/4 ml
189.64
222.65
10 %
Concentrate for infusion: Docetaxelum 80mg / 4ml
Accord Healthcare AG
A / SL / SG
FB
G
IP
Docetaxel Accord 160 mg/8 ml
379.28
428.90
10 %
Concentrate for infusion: Docetaxelum 160mg / 8ml
Accord Healthcare AG
A / SL / SG
FB
G
L
IP
CI
Prasugrel-Mepha 5 mg
30 mg
34.95
54.45
10 %
Coated tablets: Prasugrelum 5 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Prasugrel-Mepha 5 mg
100 mg
116.51
143.15
10 %
Coated tablets: Prasugrelum 5 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Prasugrel-Mepha 10 mg
30 mg
34.95
54.45
10 %
Coated tablets: Prasugrelum 10 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Prasugrel-Mepha 10 mg
100 mg
116.51
143.15
10 %
Coated tablets: Prasugrelum 10 mg
Mepha Pharma AG
●
B / SL / SG
FB
G
L
IP
V/S
Vaxelis 0.5 ml
51.14
72.05
10 %
Injection suspension: 10 Active Agents
Future Health Pharma
GmbH
B / SL
FB
G
IP
Monofer 100 mg / 1 ml
5 x 1 ml
131.65
159.60
10 %
Solution for intravenous injection/infusion: Ferrum(iii) 100 mg
Pierre Fabre Pharma SA
B / SL
FB
G
IP
Monofer 500 mg / 5 ml
5 ml
131.65
159.60
10 %
Solution for intravenous injection/infusion: Ferrum(iii) 500 mg
Pierre Fabre Pharma SA
B / SL
FB
G
IP
Monofer 500 mg / 5 ml
5 x 5 ml
658.26
732.30
10 %
Solution for intravenous injection/infusion: Ferrum(iii) 500 mg
Pierre Fabre Pharma SA
B / SL
FB
G
IP
Monofer 1000 mg / 10 ml
10 ml
263.30
302.75
10 %
Solution for intravenous injection/infusion: Ferrum(iii) 1000 mg
Pierre Fabre Pharma SA
B / SL
FB
G
IP
Monofer 1000 mg / 10 ml
2 x 10 ml
526.61
589.15
10 %
Solution for intravenous injection/infusion: Ferrum(iii) 1000 mg
Pierre Fabre Pharma SA
B / SL
FB
G
L
IP
CI
Fampyra 10 mg
56
224.09
260.15
10 %
Delayed release tablets: Fampridinum 10 mg
Merz Pharma (Schweiz) AG
B / SL
FB
G
IP
CI
Saflutan
3 ml
18.22
36.25
10 %
collyre (multidose): Tafluprostum 15 µg/ml
Santen SA
B / SL
FB
G
L
IP
CI
Procysbi 25 mg
60
329.25
374.50
10 %
gélules gastro-résistantes: Mercaptaminum 25 mg
Chiesi SA
B / SL
FB
G
L
IP
Procysbi 75 mg
250
4115.63
4492.40
10 %
gélules gastro-résistantes: Mercaptaminum 75 mg
Chiesi SA
B / SL
FB
G
IP
V/S
Vaxelis 0.5 ml
10
PR
PR
k.A.
Injection suspension: 10 Active Agents
Future Health Pharma
GmbH
B
FB
G
IP
V/S
Vaxelis 0.5 ml
10
PR
PR
k.A.
Injection suspension: 10 Active Agents
Future Health Pharma
GmbH
B
FB
G
IP
CI
CM
Sun Store Cetirizin
10
PR
PR
k.A.
Coated tablets: Cetirizini Dihydrochloridum 10 mg
Sun Store Health Care AG
D
FB
G
IP
CI
Liohem 10 mg
50
PR
PR
k.A.
Tablets: Baclofenum 10 mg
Hemony Pharmaceutical
Switzerland GmbH
B
FB
G
IP
Liohem 25 mg
50
PR
PR
k.A.
Tablets: Baclofenum 25 mg
Hemony Pharmaceutical
Switzerland GmbH
B
FB
G
IP
CI
Efavirenz/Emtricitabin/Tenofovir
Viatris
30
526.02
588.50
k.A.
Mylan: 3 Active Agents
Viatris Pharma GmbH
A
FB
G
IP
CI
Saflutan
5 ml
PR
PR
k.A.
collyre (multidose): Tafluprostum 15 µg/ml
Santen SA
B
FB
G
IP
CI
Saflutan
7 ml
PR
PR
k.A.
collyre (multidose): Tafluprostum 15 µg/ml
Santen SA
B
FB
G
IP
CI
Saflutan
3 x 3 ml
PR
PR
k.A.
collyre (multidose): Tafluprostum 15 µg/ml
Santen SA
B
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
